Interestingly, NSCLC patients with IFN I and CDKN2A gene HDs have a significantly worst disease free survival than patients with only CDKN2A gene HD (22), suggesting a tumor suppressor role for IFN I genes in this cancer. This evidence concerns the gene CDKN2A and neoplasm.